Immupharma Share Discussion Threads

[hamhamham1] 08/4/2018 10:28

Tempted? If so, it’s vital to consider the flip side of this investment.

A word of warning
Despite the encouraging outcomes of previous trials, the possibility of the drug failing to impress still remains. Plenty of highly promising treatments have disappointed at the last hurdle, resulting in significant capital losses for investors. Unless you’re willing to embrace this level of risk, Immupharma shouldn’t even make it on to your watchlist, let alone into your portfolio.

That’s why — as a holder of its stock — only a small proportion of my capital is invested in the company. This money can be lost. I might grumble and curse but — thanks to a degree of diversification — I won’t lose my shirt.

[hamhamham1] 08/4/2018 10:28

Tempted? If so, it’s vital to consider the flip side of this investment.

A word of warning
Despite the encouraging outcomes of previous trials, the possibility of the drug failing to impress still remains. Plenty of highly promising treatments have disappointed at the last hurdle, resulting in significant capital losses for investors. Unless you’re willing to embrace this level of risk, Immupharma shouldn’t even make it on to your watchlist, let alone into your portfolio.

That’s why — as a holder of its stock — only a small proportion of my capital is invested in the company. This money can be lost. I might grumble and curse but — thanks to a degree of diversification — I won’t lose my shirt.

[hamhamham1] 08/4/2018 10:27

Ok easy. Here we go then...

[easymonez] 08/4/2018 10:12

Hamham the sad little tramp
Lost all his money on the cloudtag ramp
He hasn't got a willly
He hasn't got a foo
And all the Imm holders know he hasn't got a clue

He's trying hard to close his short
But cannot catch a break
Imm the rocket ship keeps climbing
Volume is just great

[glennrcharles] 08/4/2018 10:11

I have always thought that IMM would have a plan B and this latest article makes me think that they probably do. only losing 50% on bad news implies either that complete failure is not an option or that there are other positive news on other strings to their bow waiting for release. I hope so..

[divinessence] 08/4/2018 09:56

Thank you miavoce. Totally agree. But the nasty and sad ones here will try to make a song and dance out of it.

Sunday Times Article is quite good though.

[rnsday] 08/4/2018 09:53

We have imm in the Sunday times today, more than one reasonable explanation for sm not doing the talk and we have negative posts from ham what a surprise but don't worry people he is long like the rest of us 🤔...ye ok 😂 thought he might have been posting by the name deadly today.

[miavoce] 08/4/2018 09:53

Hi Divinessence

as the cancellation was present on the website at 05:59 on the 5th I would surmise that it must have been posted there on the 4th or earlier.

I can't imagine that the institute was informed by SM of the rescheduling in the wee early hours of the 5th and then somebody got out of bed and updated the website.

[top tips] 08/4/2018 09:52

Minimum IMM fair value share price on Lupuzor success for lupus is £179 and a lot more if a larger market share plus other indications.

[hamhamham1] 08/4/2018 09:44

Divine. The double standards here are deafening.

[hamhamham1] 08/4/2018 09:42

Fuji99. Hope for the best but prepare for the worst. Never a more apt saying for here.

[divinessence] 08/4/2018 09:42

hamhamham you nasty character, go back and read maivoc account, her presentation was infact cancelled on 5th April due to air controller issues, before the DB Lock. You have read that and you are being deliberately negative. You are a very sad man. I did have you filtered, not sure what happened.

[miavoce] 08/4/2018 09:41

Hi Pretax - I don't think it is even a 'minor conference' - it appears to be one of a series of lectures in an information exchange program organised by the French embassy. Irrespective of the timing ref the P3 results the travel disruption seems to be a perfectly good reason for rescheduling.

[money maker1] 08/4/2018 09:37

Results out this week according to scws followed by a takeover 'inevitable':

[pretax2] 08/4/2018 09:35

SM lecture cancellation
"It also says that the lecture will be rescheduled to an alternative date."

This is an important moment for Lupuzor, SM doesn't want to be at some minor conference in the back of beyond. I've no doubt when the conference was planned she will have thought the trial results would be out based on the original timescale. So a delay in the talk would be better for all.

Of course the fact that she'll willing to reschedule could be seen as positive! ;-)

[bargainbob] 08/4/2018 09:17

Mr Bean travelled through France with no money . Not an excuse.:-)

[fuji99] 08/4/2018 09:16

Hamham is now worried about travel means of others after being worried about risks for PI's. A charitable soul. You may have missed the bus, not the train, on here yourself. I see now IMM taken over within a year. What can you do about it ?

[watchman50] 08/4/2018 09:13

Good to see the article in The Times - a bit more prestigious and reliable than some of the speculation on this BB. Good to get some insight of how they view things at Bryan Garnier & Co too - particularly regarding where they see the price going in the event of bad results (half = 86). Its been a key plank of my evaluation of risk/reward here that those saying that the price would suddenly drop to 10p-20p range on bad results are missing the point that with the £10m in the bank combined with the current pipeline as it stands (i.e. with the various Phase 1/2 results for the different compounds) there is still significant IP value for any takeover and I've said all along IMHO I couldn't see it dropping below 50p (maybe now I should revise this figure upwards as I'm sure Bryan Garnier & Co know more than I do).
No doubt we will see many conspiracy theories, over-estimations & under-estimations on this BB between now and results day but I will not be paying any attention to speculation on this board that isn't supported by a link to any real world news items.

[spawny100] 08/4/2018 09:06

Fantastic article in Sunday Times. I find their assessment of potential as a doubler somewhat underwhelming. Perhaps designed to keep out greedy ramping riffraff PI's?

[hamhamham1] 08/4/2018 09:04

I just don't see why SM couldn't drive or train to Switzerland or Germany then get a flight from there?
It's a valid question.

[stanman] 08/4/2018 09:00

It seems to me that major difficulties in travelling to and from from Strasbourg to Rabat is a pretty good reason for re-scheduling SM's talk. She must be a very busy lady and would no doubt prefer to be working in the lab with her team looking at possible treatments for the 100's of other autoimmune diseases that some posters here keep reminding us about. Certainly doing that rather than hanging about at airports. Also the lecture has not been cancelled - so she can go to Rabat and talk to those interested about the uselessness of Lupuzor in a couple of months time then !!!!Finally, I don't think that the series of talks in Morocco are one of the world's most prestigious conferences in the field (with all due respect to Rabat). It would be entirely appropriate for SM to be the first to present the P3 Lupuzor results (and to speculate about Lupuzor's future prospects) at a medico-scientific conference but she ought really to do that at one of world's more prestigious meetings. That could be well be after the P3 results RNS. No problem.

[113mike] 08/4/2018 08:55

Hamhead clutching at straws now.IMM firmly on the launch pad now imho!